China Looks to Build Pharma Giants

The transcript discusses China's rapid evolution from a chemical manufacturing hub to a burgeoning biotech industry. It highlights significant investments, the establishment of biotech parks, and the recruitment of highly trained scientists, including those returning from Western countries. Regulatory changes have made it easier for companies to innovate and gain approvals, creating a favorable environment for biotech growth. Despite the challenges, China is focusing on cutting-edge treatments like gene therapy, targeting its vast population with high incidences of diseases.

In what ways are Chinese drugmakers attracting talent from abroad?

What are the implications of China's large population on its biotechnology market?